Jinarc Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

30 mg: Each 30 mg tablet contains 30 mg of tolvaptan.
45 mg + 15 mg: Each 15 mg tablet contains 15 mg of tolvaptan.
Each 45 mg tablet contains 45 mg of tolvaptan.
60 mg + 30 mg: Each 30 mg tablet contains 30 mg of tolvaptan.
Each 60 mg tablet contains 60 mg of tolvaptan.
90 mg + 30 mg: Each 30 mg tablet contains 30 mg of tolvaptan.
Each 90 mg tablet contains 90 mg of tolvaptan.
Excipient(s) with known effect: 30 mg: Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
45 mg + 15 mg: Each 15 mg tablet contains approximately 35 mg lactose (as monohydrate).
Each 45 mg tablet contains approximately 12 mg lactose (as monohydrate).
60 mg + 30 mg: Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Each 60 mg tablet contains approximately 16 mg lactose (as monohydrate).
90 mg + 30 mg: Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Each 90 mg tablet contains approximately 24 mg lactose (as monohydrate).
Excipients/Inactive Ingredients: Maize starch, Hydroxypropylcellulose, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Indigo carmine (E132) aluminium lake.

tolvaptan

Manufacturer:

Otsuka

Distributor:

Zuellig

Agencia Lei Va Hong